Sugammadex is associated with shorter hospital length of stay after open lobectomy for lung cancer: a retrospective observational study.

Background: Sugammadex is associated with few postoperative complications. Postoperative pulmonary complications (PPC) are related to prolonged hospitalizations. Present study explored whether the use of sugammadex could reduce PPCs and thereby reduce hospital length of stay (LOS) after lung surgery.